See June's 10 most read stories, including the vegan supplement market in India, krill oil product recall in South Korea, and more.
India’s vegan supplement firm Unived has launched wholly plant-based multivitamins and vitamin B complex capsules to tackle what it believes was a major gap in the local market.
South Korea’s authorities have recalled 12 krill oil products after safety tests found banned substances or excessive use of solvents in the products, leading to the authorities calling for tougher inspections at customs.
In this round-up, we look at new developments from both big and local brands, such as Australia's Jatenergy's launch of lactoferrin-enriched milk powder, Swisse's plans to roll out supplements with upcycled grape seed extract, and Dabur India's COVID-19 clinical trial with its ayurvedic supplement.
India’s national research institute, the Indian Institute of Integrative Medicine (IIIM), will conduct a clinical trial on a zinc supplement that it claims has a higher bioavailability to support recovery in COVID-19 patients.
The future of microbiome and immunity research should delve deeper into the mechanisms of probiotics through clinical trials, focus on the broader role of metabolites, and consider the use of multi-omics, said an expert panel.
Australia’s complementary medicines sector continues to surge, with the sector officially valued at AUD$5.6bn last year (US$3.9bn), up from AUD$5.2bn (US$3.5bn) in 2018, while exports grew by another 15% to AUD$1.1bn (US$766m).
Yakult Japan has launched its first shelf-stable probiotic supplement – a sachet containing two of its exclusive probiotic strains, its lactic acid bacteria (Lactobacillus casei strain Shirota) and bifidobacteria (Bifidobacterium breve strain Yakult).
A two-week clinical trial led by renowned Chinese pulmonologist Zhong Nanshan has shown that consuming the botanical TCM product Lianhua Qingwen (LH) capsules and undergoing the standard therapy can speed up recovery in COVID-19 patients.
More companies in APAC are seeking to increase the amount of micronutrient fortification in their food and beverages products on the back of COVID-19, says DSM.
Nestle Health Science aims to launch nine new products from the Garden of Life series – a US health foods brand which it previously acquired – into the China market this year. Of which, immune, beauty, and anti-stress are the key product priorities.
